Synaptic injury in the IPL of the retina is linked to MS progression, with IPL thickness as a potential biomarker. Hypoxia in MS patients exacerbates inflammation and mitochondrial damage, ...

Researchers have developed a new and unique blood test to measure the immune response to the Epstein Barr Virus (EBV) which is the leading risk factor for developing multiple sclerosis (MS). Their ...

Ludwig Kappos, MD, a neurologist in Switzerland, wins the 2026 Dystel Prize for his work advancing understanding of MS.

The diagnostic criteria for MS reflect a growing understanding of the condition and the application of new advancements in medical technology to help improve diagnostic accuracy and reliability.

After decades of effort, scientists have made real progress in understanding multiple sclerosis. While researchers long knew it was an autoimmune disorder that damages the myelin sheath that serves to ...

In older people with MS, having fatigue and limited leg function is more often seen in people with MS progression than in those without, according to a preliminary study released today that will be ...

Multiple sclerosis (MS) is recognized as one of the most prevalent neurological diseases among young adults, with symptoms typically emerging between ages 20 to 40 years. The condition is ...

If you live with multiple sclerosis (MS) that has recently shifted from relapsing-remitting MS (RRMS) to secondary-progressive MS (SPMS), youre not alone. Research shows that around 62 percent of ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the relapsing-remitting (RR) disease course. This means that people have relapses -- also ...

Philippa Donnelly from Helen’s Bay, said: ''I was diagnosed with MS when I was 24. I had been noting down "strange" symptoms I was experiencing - numbness in different parts of my body, vision issues, ...